D-0184-2020 Class II
FDA drug recall D-0184-2020 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 1, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Presence of NDMA impurity detected in product.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2019
- Initiation Date
- Oct 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA) OTC
Reason for recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Distribution pattern
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Code information
Batch Numbers: All lots within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0184-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026